logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Skin And Soft Tissue Infection

    Medications for Skin And Soft Tissue Infection

    FiltersReset Filters
    7 results

    • amikacin sulfate

      (Amikacin Sulfate)
      Mullan Pharmaceutical Inc.
      Usage: Amikacin Sulfate Injection is indicated for the short-term treatment of serious infections caused by susceptible Gram-negative bacteria, including Pseudomonas and Escherichia coli, among others. It is effective in conditions such as septicemia, respiratory tract infections, and complicated urinary tract infections, and may also treat staphylococcal infections under specific circumstances.

    • amikacin sulfate

      (Amikacin Sulfate)
      Qilu Pharmaceutical Co., Ltd.
      Usage: Amikacin Sulfate Injection is indicated for short-term treatment of serious infections from susceptible Gram-negative bacteria, including Pseudomonas and E. coli. It is effective in septicemia, respiratory infections, urinary tract infections, and mixed infections alongside staphylococci. Usage should be guided by susceptibility tests to reduce drug resistance.

    • cefazolin

      (cefazolin sodium)
      Sagent Pharmaceuticals
      Usage: Cefazolin for Injection is indicated for treating serious infections caused by susceptible organisms, including respiratory, urinary, skin, biliary, bone, joint infections, septicemia, endocarditis, and for perioperative prophylaxis to reduce postoperative infections during contaminated surgeries. Its use should be guided by culture and susceptibility data.

    • cefazolin

      (Cefazolin)
      Hospira, Inc
      Usage: Cefazolin for injection is indicated for treating serious infections, including respiratory, urinary, skin, biliary, bone, joint, genital infections, septicemia, and endocarditis caused by susceptible organisms. It also serves as prophylaxis for certain surgical infections, particularly in high-risk patients.

    • cefazolin

      (Cefazolin)
      WG Critical Care, LLC
      Usage: Cefazolin for Injection, USP is indicated for serious infections caused by susceptible organisms, including respiratory, urinary, skin, biliary, bone, joint, genital infections, septicemia, endocarditis, and for perioperative prophylaxis to reduce postoperative infections in high-risk surgical patients. Use is to treat or prevent targeted infections.

    • cleocin pediatric

      (clindamycin palmitate hydrochloride)
      Pharmacia & Upjohn Company LLC
      Usage: CLEOCIN PEDIATRIC (clindamycin palmitate HCl) is indicated for treating serious infections caused by susceptible anaerobic bacteria, streptococci, pneumococci, and staphylococci. It is reserved for penicillin-allergic patients or when penicillin is inappropriate, with caution due to the risk of colitis.

    • clindamycin hydrochloride

      (Clindamycin Hydrochloride)
      GLENMARK PHARMACEUTICALS INC., USA
      Usage: Clindamycin is indicated for treating serious infections caused by susceptible anaerobic bacteria and strains of streptococci, pneumococci, and staphylococci, especially in penicillin-allergic patients. It is effective for respiratory, skin, soft tissue, and intra-abdominal infections but carries a risk of colitis.